162 related articles for article (PubMed ID: 36524682)
1. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease.
Lin PB; Tsai AP; Soni D; Lee-Gosselin A; Moutinho M; Puntambekar SS; Landreth GE; Lamb BT; Oblak AL
Alzheimers Dement; 2023 Jun; 19(6):2528-2537. PubMed ID: 36524682
[TBL] [Abstract][Full Text] [Related]
2. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology.
Samuels JD; Moore KA; Ennerfelt HE; Johnson AM; Walsh AE; Price RJ; Lukens JR
Alzheimers Dement; 2023 Nov; 19(11):4908-4921. PubMed ID: 37061460
[TBL] [Abstract][Full Text] [Related]
3. Pathological Roles of INPP5D in Alzheimer's Disease.
Chu YN; Akahori A; Takatori S; Tomita T
Adv Exp Med Biol; 2023; 1423():289-301. PubMed ID: 37525057
[TBL] [Abstract][Full Text] [Related]
4. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia.
Tsai AP; Lin PB; Dong C; Moutinho M; Casali BT; Liu Y; Lamb BT; Landreth GE; Oblak AL; Nho K
Neurobiol Dis; 2021 Jun; 153():105303. PubMed ID: 33631273
[TBL] [Abstract][Full Text] [Related]
5. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
6. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease.
Castranio EL; Hasel P; Haure-Mirande JV; Ramirez Jimenez AV; Hamilton BW; Kim RD; Glabe CG; Wang M; Zhang B; Gandy S; Liddelow SA; Ehrlich ME
Alzheimers Dement; 2023 Jun; 19(6):2239-2252. PubMed ID: 36448627
[TBL] [Abstract][Full Text] [Related]
7. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
von Saucken VE; Jay TR; Landreth GE
Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
[TBL] [Abstract][Full Text] [Related]
9. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
[TBL] [Abstract][Full Text] [Related]
10. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
[TBL] [Abstract][Full Text] [Related]
11. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
12. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
Katsouri L; Georgopoulos S
PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
[TBL] [Abstract][Full Text] [Related]
13. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.
Zhao P; Xu Y; Jiang L; Fan X; Li L; Li X; Arase H; Zhao Y; Cao W; Zheng H; Xu H; Tong Q; Zhang N; An Z
Sci Transl Med; 2022 Sep; 14(661):eabq0095. PubMed ID: 36070367
[TBL] [Abstract][Full Text] [Related]
14. Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a
Parhizkar S; Gent G; Chen Y; Rensing N; Gratuze M; Strout G; Sviben S; Tycksen E; Zhang Q; Gilmore PE; Sprung R; Malone J; Chen W; Remolina Serrano J; Bao X; Lee C; Wang C; Landsness E; Fitzpatrick J; Wong M; Townsend R; Colonna M; Schmidt RE; Holtzman DM
Sci Transl Med; 2023 Apr; 15(693):eade6285. PubMed ID: 37099634
[TBL] [Abstract][Full Text] [Related]
15. Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy.
Soni DM; Lin PB; Lee-Gosselin A; Lloyd CD; Mason E; Ingraham CM; Perkins A; Moutinho M; Lamb BT; Chu S; Oblak AL
Alzheimers Dement; 2024 Jun; ():. PubMed ID: 38923171
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
[TBL] [Abstract][Full Text] [Related]
17. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
18. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
[TBL] [Abstract][Full Text] [Related]
19. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
20. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]